NCT04829149
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Hanmi Pharmaceutical Company Limited Seoul, South Korea
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
279 public trials
34 recruiting studies
Dyslipidemias trial results
NCT03527290
- Conditions
- Blood Pressure, Body Weight, Body Weight Changes, +15 more
- Locations
-
- Institute for Clinical and Translational Science Irvine, California, United States
Completed
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
NCT04807959
- Conditions
- Body Weight, Cardiovascular Diseases, Central Obesity, +22 more
- Locations
-
Not specified
NCT04802525
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Marwa Eid Cairo, Egypt
NCT00540293
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Daegu, Korea, South Korea
- Pfizer Investigational Site Seoul, Korea, South Korea
- Pfizer Investigational Site Busan, South Korea
- Pfizer Investigational Site Busan, South Korea
NCT02726100
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +8 more
- Locations
-
- Hebei Medical University Shijiazhuang, Hebei, China
- Center of Disease Control and Prevention, Luquan Shijiazhuang, Hebei, China
NCT00644709
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Brasschaat, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Genk, Belgium
NCT00647543
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Bangkok, Thailand
- Pfizer Investigational Site Bangkok, Thailand
- Pfizer Investigational Site Chiang Mai, Thailand
- Pfizer Investigational Site
NCT00645151
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Belo Horizonte, Minas Gerais, Brazil
- Pfizer Investigational Site Curitiba, Paraná, Brazil
- Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
- Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
NCT00644670
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Brasschaat, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Edegem, Belgium